Study calls for reviews of psychotropic medication use in elderly

(Medical Xpress)—Regular clinical reviews of psychotropic medication should be established in all care homes to promote safe and effective prescribing to an at-risk population of elderly people, according to a new study by researchers at the University of Dundee and NHS Fife, published today in Age & Ageing, the scientific journal of the British Geriatrics Society.

The use of psychotropic drugs - such as antipsychotics and antidepressants - in older people has long been of concern, particularly among those who are in nursing homes. A recent UK Parliamentary report expressed concern that their `inappropriate use' in care homes was a 'means of controlling patients'. There have also been recommendations that there should be a reduction of use of antipsychotic drugs in older people with dementia across the UK.

The new study shows that approximately 1 in 6 older people receive at least one psychotropic medication in a 2-year period. The figure rises to 2 in 5 among nursing home residents.

However, the study found that the majority of psychotropic drugs used by nursing home residents were started prior to the patient being admitted, and for those who started antipsychotics just prior to admission it was more likely the person would continue to receive the drugs.

"This study presents a complex picture of the prescribing and use of these medicines," said Colin McCowan, Deputy Director of the Health Informatics Centre at the University of Dundee. "Psychotropic use is significantly higher in care home residents but they would seem to be initiated primarily before people are admitted.

"This may be evidence against the belief that initiation is largely driven by care home staff to make residents easier or more convenient to manage.

"There may be valid reasons for the initiation of these drugs but prolonged use of psychotropic medication in is not recommended and may cause harm. The key issue our study suggests is that there should be systematic medication reviews for patients on these drugs, to highlight drugs that may be discontinued if the reasons for their initial prescription are no longer valid."

The study compared the prescribing of psychotropic medications in Tayside for patients living in to patients living at home. It used data gathered over a two-year period.

Previous research has shown that many of the antipsychotics being prescribed to patients are likely to be having very little beneficial effect, and can be reduced and usually stopped.

Stella Clark, of Fife, said there were some promising signs in prescribing patterns but that national guidance still needed to be developed.

"We have recently seen data for the whole of England which showed a reduction in the prescription of antipsychotics to people with dementia," said Stella.

"This is a really important area of prescribing where changes can be made which will improve patient safety and there is a clear need for national guidance to be developed."

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments